Search Results - Orofino J
- Showing 1 - 2 results of 2
-
1
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer by Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain by Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book